MLCCs deliver reliable performance required in life support applications

AVX Corporation has released the MQ Series medical grade of MLCCs. Manufactured, tested, and qualified using stringent medical design, in-process, and lot acceptance requirements, the series medical grade MLCCs deliver the superior reliability performance required by electronic life support applications, including: pacemakers, implantable cardioverter-defibrillators, and neuromodulation devices. Available in several different dielectrics, case sizes, voltage and capacitance ratings, and termination options, the series also offers exceptional versatility. “AVX has a long history of providing advanced design, manufacturing, testing, and qualification services for the medical industry, and we’re proud to be an industry-leading developer and supplier of medically qualified MLCCs and other passive components,” said Lizzie Geismar, product manager, AVX. “We design all of our medical components with our customers in mind, and, as such, our MQ Series MLCCs provide medical device engineers with both the utmost reliability and design flexibility, enabling the next generation of electronic life support applications.” The medical-grade MLCCs are available in eight EIA case sizes spanning 0402 to 2225, and four dielectric materials: NP0 (C0G), X7R, X7S, and X5R. Voltage ratings for the series range from 4V to 100V, capacitance values span 1pF to 100µF, and capacitance tolerances extend from ±0.1pF to ±30%. The capacitors are also available with four termination options: plated Ni/Sn, 60/40 Sn/Pb, 5% minimum Pb-plated solder, and gold plated.